Clinical Impacts of Sacubitril/Valsartan on Patients Eligible for Cardiac Resynchronization Therapy

Abstract

Despite SAC/VAL treatment, wide QRS durations are associated with lower degrees of left ventricular improvement than narrow ones in the HFrEF patients. Optimal intervention timing for the CRT-eligible patients requires further investigation.